Liver function and drug safety: a closer look at quizartinib
NCT ID NCT06740799
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This study looks at how the drug quizartinib is processed in people with severe liver problems compared to healthy people. About 12 adults will receive a single dose, and researchers will measure drug levels and side effects. The goal is to understand how liver impairment affects the drug, not to treat the liver condition itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advanced Pharma
RECRUITINGMiami, Florida, 33147, United States
-
Clinical Pharmacology of Miami, LLC
RECRUITINGMiami, Florida, 33014, United States
-
GCP Research
RECRUITINGSt. Petersburg, Florida, 33705, United States
Conditions
Explore the condition pages connected to this study.